These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Mumford JP; Dam M Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):101S-107S. PubMed ID: 2667602 [TBL] [Abstract][Full Text] [Related]
8. Vigabatrin in the treatment of complex partial seizures. Knott C; Panayiotopoulos CP Seizure; 1992 Sep; 1(3):167-72. PubMed ID: 1344762 [TBL] [Abstract][Full Text] [Related]
9. Vigabatrin as an anticonvulsant against pentylenetetrazol seizures. Sayin U; Cengiz S; Altug T Pharmacol Res; 1993 Dec; 28(4):325-31. PubMed ID: 8140032 [TBL] [Abstract][Full Text] [Related]
10. Single-blind, placebo-controlled multicenter trial of vigabatrin in the treatment of epilepsy. The Italian Study Group on Vigabatrin. Ital J Neurol Sci; 1992 Dec; 13(9):741-7. PubMed ID: 1483856 [TBL] [Abstract][Full Text] [Related]
11. Vigabatrin: a novel therapy for seizure disorders. Gidal BE; Privitera MD; Sheth RD; Gilman JT Ann Pharmacother; 1999 Dec; 33(12):1277-86. PubMed ID: 10630829 [TBL] [Abstract][Full Text] [Related]
12. Vigabatrin in adults with poorly-controlled epilepsy and learning disabilities. Armour DJ; Fidler C; Wright EC; Balarajan S Seizure; 1992 Sep; 1(3):157-62. PubMed ID: 1344760 [TBL] [Abstract][Full Text] [Related]
13. Vigabatrin for partial-onset seizure treatment in patients with tuberous sclerosis complex. Friedman D; Bogner M; Parker-Menzer K; Devinsky O Epilepsy Behav; 2013 Apr; 27(1):118-20. PubMed ID: 23399947 [TBL] [Abstract][Full Text] [Related]
14. The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. Lortie A; Chiron C; Mumford J; Dulac O Neurology; 1993 Nov; 43(11 Suppl 5):S24-7. PubMed ID: 8232984 [TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of the effectiveness and safety of vigabatrin]. Jedrzejczak J; Owczarek K Neurol Neurochir Pol; 2000; 34 Suppl 1():177-85. PubMed ID: 10768157 [TBL] [Abstract][Full Text] [Related]
18. Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Grant SM; Heel RC Drugs; 1991 Jun; 41(6):889-926. PubMed ID: 1715266 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy. Remy C; Beaumont D Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):125S-129S. PubMed ID: 2757903 [TBL] [Abstract][Full Text] [Related]
20. Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study. Tartara A; Manni R; Galimberti CA; Hardenberg J; Orwin J; Perucca E Epilepsia; 1986; 27(6):717-23. PubMed ID: 3536469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]